Abstract
The prevalence of hepatitis A antibodies in the adult population of the Murcia Region (south-east of Spain) was estimated using an anonymous unlinked serosurvey in a population-based sample of 2,203 adults. The overall anti-HAV prevalence was 76.5%. The prevalence increased with age and was higher in individuals living in towns with less than 10,000 inhabitants.
This is a preview of subscription content, log in via an institution to check access.
References
Papaevangelou G. Epidemiology of hepatitis A in Mediterranean countries. Vaccine 1992; 10(suppl 1): S63–S66.
Tormo MJ, Navarro C, Chirlaque D, et al. Factores de riesgo cardiovascular en la Región de Murcia, 1992. Consejería de Sanidad y Asuntos Sociales. Serie Informes, No. 20, 1995.
Global Programme on AIDS, World Health Organization. Unlinked anonymous screening for the public health surveillance of HIV infections. Proposed international guidelines. Geneva: WHO document GPA/SFI/89.3, 1989.
García-Fulgueiras A, Tormo MJ, Rodriguez T, et al. Prevalence of hepatitis B and C markers in the South-East of Spain: An unlinked community-based serosurvey of 2,203 adults. Scand J Infect Dis 1996; 28: 17–20.
Levy PS, Lemeshov S. Sampling for health professionals. Belmont, CA: Lifetime Learning Publications, 1980: 106–134.
Frösner GG, Papaevangelou G, Bütler R, et al. Antibody against hepatitis A in seven European countries, I: Comparison of prevalence data in different age groups. Am J Epidem 1979; 110: 63–69.
Pasquini P, Kahn HA, Pileggi D, et al. Prevalence of hepatitis A antibodies in Italy. Int J Epidemiol 1984; 13: 83–86.
Amela C, Pachón I, Bueno R, et al. Trends in hepatitis A virus infection with reference to the process of urbanization in the greater Madrid area (Spain). Eur J Epidem 1995; 11: 569–573.
González A, Bruguera M, Calbo Torrecillas F, et al. Encuesta seroepidemiológica de prevalencia de anticuerpos antihepatitis A en la población adulta joven española. Med Clin (Barc) 1994; 103: 445–448.
Salleras L, Bruguera M, Vidal J, et al. Cambio del patrón epidemiológico de la hepatitis A en España. Med Clin (Barc) 1992; 99: 87–89.
Vargas V, Buti M, Hernández-Sánchez JM, et al. Prevalencia de los anticuerpos contra el virus de la hepatitis A en la población general. Estudio comparativo 1977–1985. Med Clin (Barc) 1987; 88: 144–146.
Perez-Trallero E, Cilla G, Urbieta M, et al. Falling incidence and prevalence of hepatitis A in Northern Spain. Scand J Infect Dis 1994; 26: 133–136.
Joussemet M, Bourin Ph, Buisson Y, Fabre G. Diminution du taux de prévalence des anticorps anti-VHA chez les jeunes militaires de 20 ans. Bull Epidemiol Hebd 1991: 115–116.
Shapiro CN, Coleman PJ, McQuillan GM, et al. Epidemiology of hepatitis A: Seroepidemiology and risk groups in the USA. Vaccine 1992; 10(suppl 1): S59–S62.
Dubois F, Thevenas C, Caces E, et al. Sérépidémiologie de l'hépatite A dans six départments du Centre-Ouest de la France en 1991. Gastroenterol Clin Biol 1992; 16: 674–679.
Lednar WM, Lemon SM, Kirkpatrick JW, et al. Frequency of illness associated with epidemic hepatitis A virus infections in adults. Am J Epidemiol 1985; 122: 226–233.
World Health Organization. Public health control of hepatitis A: Memorandum from a WHO meeting. Bull WHO 1995; 73: 15–20.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
García-Fulgueiras, A., Rodriguez, T., Tormo, M. et al. Prevalence of hepatitis A antibodies in southeastern Spain: A population-based study. Eur J Epidemiol 13, 481–483 (1997). https://doi.org/10.1023/A:1007397906494
Issue Date:
DOI: https://doi.org/10.1023/A:1007397906494